Genome sequencing of newborns identifies more preventable or treatable health conditions than standard blood tests.

A study from NewYork-Presbyterian/Columbia University found that genome sequencing of newborns can identify many more preventable or treatable health conditions than conventional blood tests. Analyzing 4,000 newborns, researchers detected 120 serious conditions, compared to just 10 through standard methods. They advocate for genome sequencing as a new standard, as it could uncover thousands of genetic diseases, offering broader health protections for infants.

October 24, 2024
16 Articles